Reduced survival in patients requiring chest tubes with COVID-19 acute respiratory distress syndrome.

ABSTRACT:

Background

Numerous complications requiring tube thoracostomy have been reported among critically ill patients with COVID-19; however, there has been a lack of evidence regarding outcomes following chest tube placement.

Methods

We developed a retrospective observational cohort of all patients admitted to an intensive care unit (ICU) with confirmed COVID-19 to describe the incidence of tube thoracostomy and factors associated with mortality following chest tube placement.

Results

In total, 1705 patients with laboratory confirmed COVID-19 patients were admitted to our ICUs from March 7, 2020, to March 1, 2021, with 69 out of 1705 patients (4.0%) receiving 130 chest tubes. Of these, 89 out of 130 (68%) chest tubes were indicated for pneumothorax. Patients receiving tube

SUBMITTER: Rizer NW 

PROVIDER: S-EPMC9020834 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature